Bio-Techne Corp (TECH)

408.72 +3.58  +0.88% NASDAQ Apr 9, 20:00 USD
View Full Chart
Price Chart
View All TECH News

News

View All Events

Events

Date Type Description
04/30/2020 08:00 CDT Earnings Calls Q3 2020 Earnings Call
04/30/2020 00:00 Earnings Results Q3 2020 Earnings Results
05/08/2020 None Dividends 0.32 Normal, declared April 30, 2020 and paid May 22, 2020
08/04/2020 08:00 CDT Earnings Calls Q4 2020 Earnings Call
08/04/2020 00:00 Earnings Results Q4 2020 Earnings Results
08/17/2020 None Dividends 0.32 Normal, declared August 04, 2020 and paid August 28, 2020
10/29/2020 08:30 CDT Agm 2020 Annual General Meeting
11/05/2020 00:00 Earnings Results Q1 2021 Earnings Results
11/05/2020 08:00 CST Earnings Calls Q1 2021 Earnings Call
11/13/2020 None Dividends 0.32 Normal, declared November 05, 2020 and paid November 27, 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.bio-techne.com
  • Investor Relations URL: https://www.bio-techne.com/investor-relations
  • HQ State/Province: Minnesota
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 06, 2021
  • Last Earnings Release: Feb. 02, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Feb. 11, 2021
  • Description: Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells a variety of antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers, and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Top Fund Holders

Symbol Name Weighting
FBT First Trust NYSE Arca Biotech ETF 4.20%
BGRUX Baron Growth R6 3.75%
BCSIX Brown Capital Mgmt Small Co Inv 3.37%
XMMO Invesco S&P MidCap Momentum ETF 2.85%
NBGAX Neuberger Berman Genesis Adv 2.25%
BMRRX BlackRock Mid-Cap Growth Equity R 2.18%
ECASX Eaton Vance Atlanta Capital SMID-Cap C 1.86%
IJK iShares S&P Mid-Cap 400 Growth ETF 1.42%
SPMD SPDR® Portfolio S&P 400 Mid Cap ETF 0.67%
IJH iShares Core S&P Mid-Cap ETF 0.67%
VBK Vanguard Small-Cap Growth ETF 0.59%
NAESX Vanguard Small Cap Index Inv 0.27%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.